- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Mankind Pharma Limited — Board Meeting, 30-07-2026: Outcome of Board Meeting
30-07-2026 | 03:21 pm
30-07-2026 | 03:21 pm
Mankind Pharma's board approved Q1 consolidated results: Revenue ₹4,030.59 Cr, Profit ₹574.09 Cr (EPS ₹13.76). Also greenlit a ₹150 Cr guarantee for a subsidiary, divested Broadway Hospitality for ₹49 Cr, and formed a new R&D subsidiary in Netherlands.
No comments yet. Be the first to comment!